PCF Science

• Jonathan Simons, MD, President and CEO
• Stuart Holden, MD, Medical Director
• Howard Soule, PhD, Chief Science Officer and Executive Vice President
• Guneet Walia, PhD, Manager, Scientific Programs
• Audrey Gardner, Assistant to Howard Soule, PhD
• D&T Committee, Final approval of all research awards

Surgical Urologic Oncology

• Peter R. Carroll, MD, MPH, University of California, San Francisco
• Brett Carver, MD, Memorial Sloan-Kettering Cancer Center
• Ballentine Carter, MD, Johns Hopkins Medicine
• Martin Gleave, MD, University of British Columbia
• Thomas Guzzo, MD, MPH, University of Pennsylvania
• Stuart Holden, MD, Cedars-Sinai Medical Center
• Laurence Klotz, MD, University of Toronto
• David Neal, University of Cambridge
• Joel Nelson, MD, University of Pittsburgh
• Robert Reiter, MD, University of California, Los Angeles
• Martin Sanda, MD, Harvard Medical School
• Ashutosh Tewari, MBBS, Weill Cornell Medical College
• Ian Thompson, MD, The UT Health Science Center at San Antonio

Medical Oncology and Treatment Sciences   

• Andrew Armstrong, MD, Duke University
• Gerhard Attard, MD, PhD, The Royal Marsden Hospital
• Tomasz Beer, MD, FACP, Oregon Health and Science University
• William Dahut, MD, National Cancer Institute
• Ian Davis, PhD, Ludwig Institute for Cancer Research
• Johann de Bono, MD, PhD, The Royal Marsden Hospital
• Eleni Efstathiou, MD, PhD, The University of Texas MD Anderson Cancer Center
• Phillip G. Febbo, MD, University of California, San Francisco
• Daniel George, MD, Duke University
• Daniel  Haber, MD, PhD, Massachusetts General Hospital
• Hans Joerg Hammers, MD, PhD, Johns Hopkins Medicine
• Elizabeth Heath, MD, Wayne State University
• Celestia Higano, MD, University of Washington
• Andrew Hsieh, MD, University of California, San Francisco
• Phil Kantoff, MD, Dana-Farber Cancer Institute
• Christopher J. Logothetis, MD, The University of Texas MD Anderson Cancer Center
• Nicholas Mitsiades, MD, PhD, Baylor College of Medicine
• Michael Morris, MD, Memorial Sloan-Kettering Cancer Center
• Peter Nelson, MD, Fred Hutchinson Cancer Research Center
• William Oh, MD, Mt. Sinai School of Medicine
• Kenneth Pienta, MD, University of Michigan
• Roberto Pili, MD, Roswell Park Cancer Institute
• Ganesh Raj, MD, PhD, University of Texas Southwestern
• Matthew Rettig, MD, University of California, Los Angeles
• Neal Rosen, MD, PhD, Memorial Sloan-Kettering Cancer Center
• Charles Ryan, MD, University of California, San Francisco
• Oliver Sartor, MD, Tulane University
• Phillip Saylor, MD, Massachussets General Hospital
• Howard Scher, MD, Memorial Sloan-Kettering Cancer Center
• Jennifer Schutzman, MD, PhD, University of California, San Francisco
• Nima Sharifi, MD, UT Southwestern Medical Center
• Matthew Smith, MD, PhD, Massachusetts General Hospital
• David Solit, MD, Memorial Sloan-Kettering Cancer Center
• Walter Stadler, MD, University of Chicago
• Scott Tagawa, MD, Weill Cornell Medical College
• Jonathan Waxman, MD, FRCP, Hammersmith Hospital
• George Wilding, MD, University of Wisconsin
• Scott Williams, MD, Peter MacCallum Cancer Center

Immunotherapy   

• James Allison, PhD, Memorial Sloan-Kettering Cancer Center
• Charles Drake, MD, PhD, Johns Hopkins Medicine
• Lawrence Fong, MD, University of California, San Francisco
• James Gulley, MD, PhD, National Cancer Institute
• Pam Sharma, MD, PhD, MD, The University of Texas MD Anderson Cancer Center
• Eric Small, MD, University of California, San Francisco
• Jedd Wolchok, MD, PhD, Memorial Sloan-Kettering Cancer Center

Genomics   

• John Carpten, PhD, Translational Genomics Research Institute
• Colin Collins, PhD, University of British Columbia
• Phillip Febbo, MD, University of California, San Francisco
• Levi Garraway, MD, PhD, Dana-Farber Cancer Institute
• William Hahn, MD, PhD, Dana-Farber Cancer Institute
• William Isaacs, PhD, Johns Hopkins Medicine
• Christopher Maher, PhD, University of Michigan
• Lorelei Mucci, ScD, MPH, Harvard School of Public Health

Basic Science   

• Cory Abate-Shen, PhD, Columbia University
• Donald Coffey, PhD, Johns Hopkins Medicine
• Colin Cooper, MD, Queen's University, Belfast 
• Robert Getzenberg, PhD, Johns Hopkins Medicine
• John Isaacs, PhD, Johns Hopkins Medicine
• Candace Johnson, PhD, Roswell Park Cancer Institute
• Karen Knudsen, PhD, Thomas Jefferson University
• Lucia Languino, PhD, University of Massachusetts
• Ram Mani, PhD, University of Michigan
• Nora Navone, MD, PhD, The University of Texas MD Anderson Cancer Center
• Marianne Sadar, PhD, BC Cancer Agency
• Jack Schalken, PhD, University Hospital of Nijmegen
• Russell Taichman, DMD, DMSc, University of Michigan
• Muneesh Tewari, MD PhD, Fred Hutchinson Cancer Research Center
• Timothy Thompson, PhD, The University of Texas MD Anderson Cancer Center
• Robert Vessella, PhD, University of Washington
• Owen Witte, MD, University of California, Los Angeles
• Hong Wu, MD, PhD, University of California, Los Angeles
• Srinivasan Yegnasubramanian, MD, PhD, Johns Hopkins Medicine
• Amina Zoubeidi, PhD, University of British Columbia

Radiation Oncology   

• Robert Bristow, MD, PhD, University of Toronto
• Anthony D’Amico, MD, PhD, Brigham and Women’s Hospital
• Robert Den, MD, Thomas Jefferson University
• Theodore DeWeese, MD, Johns Hopkins Medicine
• Adam Dicker, MD, PhD, Thomas Jefferson University
• Felix Feng, MD, University of Michigan
• Daniel Hamstra, MD, PhD, University of Michigan
• Neil Martin, MD, Brigham and Women's Hospital
• Howard Sandler, MD, Cedars-Sinai Medical Center
• Scott Williams, MD, Peter MacCallum Cancer Centre

Nutrition Research   

• June Chan, ScD, University of California, San Francisco
• David Heber, MD, University of California, Los Angeles
• Richard Mithen, PhD, Institute of Food Research, UK
• William Nelson, MD, PhD, Johns Hopkins Medicine
• Meir Stampfer, MD, Harvard School of Public Health

Molecular Imaging   

• Peter Choyke, MD, National Cancer Institute
• Sanjiv Sam Gambhir, MD, PhD, Stanford University
• Robert Jeraj, PhD, University of Wisconsin
• Glenn Liu, MD, University of Wisconsin
• Steven Larson, MD, Memorial Sloan-Kettering Cancer Center
• Martin Pomper, MD, PhD, Johns Hopkins Medicine
• Lily Wu, MD, PhD, University of California, Los Angeles

Molecular Pathology   

• Mahul Amin, MD, Cedars-Sinai Medical Center
• Gustavo Ayala, MD, Baylor College of Medicine
• Arul Chinnaiyan, MD, PhD, University of Michigan
• Angelo DeMarzo, MD, PhD, Johns Hopkins Medicine
• Michael Ittmann, MD, PhD, Baylor College of Medicine
• Karen Kaul, MD, PhD, Northwestern University
• Beatrice Knudsen, MD, PhD, Cedars-Sinai Medical Center
• Massimo Loda, MD, Dana-Farber Cancer Institute
• Timothy McDonnell, MD, PhD, The University of Texas MD Anderson Cancer Center
• Mark Rubin, MD, Weill Cornell Medical College
• Jeffrey Simko, MD, PhD, University of California, San Francisco
• Scott Tomlins, MD, PhD, University of Michigan

Statistics   

• Susan Halabi, PhD, Duke University
• Steven Piantadosi, MD, PhD, Cedars-Sinai Medical Center
• Bruce Trock, PhD, Johns Hopkins Medicine